Hims & Hers Health (NYSE:HIMS) shut down Apostrophe on Friday, the skincare business it acquired in 2019 for $190M. A message ...

Apostrophe, a skin care telehealth brand headquartered in the Bay Area, is shutting down after almost four years under the ...

Hims & Hers Health has called time on Apostrophe, its personalised acne treatments business. The San Francisco-based ...

We recently compiled a list of the 10 Best Skincare Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operations ...

with services spanning from skin care and hair loss to anxiety and erectile dysfunction. This review examines its erectile dysfunction (ED) services, looking closely at what Hims offers its users ...

Apostrophe is being shut down to “simplify its (company’s) dermatology products and operations into one seamless experience,” Hims & Hers said. The telehealth company, which also offers products for ...

We evaluate services for consistency with standards of care and best ... Dudum commented on his skin issues. Focused on full-service telemedicine for men’s health, Hims provides digital ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

The brand, which entered Target just two years ago, will no longer accept orders on its website after March 24.

Hims & Hers Health Inc. has acquired a California ... Other peptides are commonly found in over-the-counter supplements and skin-care products, with some being promoted for supposed longevity ...

Changes are afoot in the teledermatology space. As Hims & Hers shutters Apostrophe, the teledermatology specialist it ...